Get the Stockscreener App
15.30
0.23%
0.035
After Hours:
15.30
Inmode Ltd stock is traded at $15.30, with a volume of 914.87K.
It is up +0.23% in the last 24 hours and up +3.17% over the past month.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
See More
Previous Close:
$15.27
Open:
$15.72
24h Volume:
914.87K
Relative Volume:
0.96
Market Cap:
$967.10M
Revenue:
$492.05M
Net Income/Loss:
$197.92M
P/E Ratio:
6.6522
EPS:
2.3
Net Cash Flow:
$176.12M
1W Performance:
+0.46%
1M Performance:
+3.17%
6M Performance:
+2.82%
1Y Performance:
-7.27%
1-Day Range:
$14.97
$15.74
1-Week Range:
$14.89
$16.74
52-Week Range:
$13.14
$19.85
Inmode Ltd Stock (INMD) Company Profile
Compare INMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
15.30 | 964.89M | 492.05M | 197.92M | 176.12M | 2.30 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-28-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-17-24 | Initiated | BTIG Research | Buy |
| Jul-23-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-03-23 | Downgrade | UBS | Buy → Neutral |
| Oct-13-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-29-23 | Initiated | UBS | Buy |
| Feb-17-23 | Downgrade | Needham | Buy → Hold |
| Dec-21-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| May-18-21 | Initiated | Needham | Buy |
| Sep-03-19 | Initiated | Barclays | Overweight |
| Sep-03-19 | Initiated | Canaccord Genuity | Buy |
| Sep-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-03-19 | Initiated | UBS | Buy |
View All
Inmode Ltd Stock (INMD) Latest News
Will InMode Ltd. stock see insider buying2025 Market Sentiment & Daily Profit Focused Screening - newser.com
Can momentum traders help lift InMode Ltd.Chart Signals & Reliable Price Action Trade Plans - newser.com
Will InMode Ltd. stock go up soonNew Guidance & Safe Entry Momentum Tips - newser.com
Canaccord Genuity Group Boosts InMode (NASDAQ:INMD) Price Target to $16.00 - MarketBeat
InMode (NASDAQ:INMD) Given "Hold" Rating at Needham & Company LLC - MarketBeat
InMode stock revenue beats expectations, Needham maintains Hold By Investing.com - Investing.com Nigeria
Canaccord Genuity Maintains InMode (INMD) Hold Recommendation - Nasdaq
InMode Ltd. Experiences Revision in Stock Evaluation Amid Market Dynamics and Performance Challenges - Markets Mojo
InMode (NASDAQ:INMD) Shares Gap UpWhat's Next? - MarketBeat
InMode (INMD): Canaccord Genuity Maintains Hold Rating, Raises P - GuruFocus
InMode stock price target raised to $16 from $14 at Canaccord Genuity - Investing.com Nigeria
InMode price target raised to $16 from $14 at Canaccord - TipRanks
InMode stock revenue beats expectations, Needham maintains Hold - Investing.com India
InMode Ltd. Provides Earnings Guidance for the Third Quarter and Reaffirms Earnings Guidance Full Year 2025 - MarketScreener
InMode stock rises after preliminary Q3 revenue tops estimates By Investing.com - Investing.com Nigeria
InMode stock rises after preliminary Q3 revenue tops estimates - Investing.com India
$92.5M–$93.0M Q3 revenue — InMode to report results Nov. 5; reiterates FY 2025 guidance $365M–$375M - Stock Titan
Weiss Ratings Reiterates "Sell (D+)" Rating for InMode (NASDAQ:INMD) - MarketBeat
Is InMode Ltd. (154) stock cheap by valuation metricsTrade Signal Summary & Free Accurate Trade Setup Notifications - newser.com
What analysts say about InMode Ltd 154 stockValue Stock Picks & Big Profit Low Trading - earlytimes.in
What analysts say about InMode Ltd stockTechnology Stock Trends & Exceptional Capital Investment - earlytimes.in
How InMode Ltd. (154) stock reacts to stronger dollarQuarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com
Applying Elliott Wave Theory to InMode Ltd.Bond Market & Community Shared Stock Ideas - newser.com
How to use a screener to detect InMode Ltd. breakoutsTrade Exit Report & Real-Time Volume Spike Alerts - newser.com
Analyzing InMode Ltd. with risk reward ratio chartsJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
InMode (NASDAQ:INMD) Upgraded at Zacks Research - MarketBeat
InMode Ltd 154 Stock Analysis and ForecastCapital Gains Strategies & Daily Tips From Top Market Analysts - earlytimes.in
Is InMode Ltd a good long term investmentGrowth Stock Opportunities & High Return Stock Ideas - earlytimes.in
InMode Ltd. (NASDAQ:INMD) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Focus Partners Wealth Boosts Stock Position in InMode Ltd. $INMD - MarketBeat
Targets Report: Does InMode Ltd. align with a passive investing strategyJuly 2025 Technicals & Fast Gain Swing Alerts - خودرو بانک
Inmode Ltd Stock (INMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):